Workflow
云南白药(000538) - 2024年7月3日调研活动附件之投资者调研会议记录
YUNNAN BAIYAOYUNNAN BAIYAO(SZ:000538)2024-07-05 09:46

Financial Performance - In Q1 2024, the company achieved revenue of CNY 10.774 billion, a year-on-year increase of 2.49% [2] - The net profit attributable to shareholders was CNY 1.702 billion, up 12.12% year-on-year [2] - For the full year 2023, total revenue reached CNY 39.111 billion, an increase of 7.19% from CNY 36.488 billion in 2022 [2] - The net profit attributable to shareholders for 2023 was CNY 4.094 billion, a significant rise of 36.41% [2] - The basic earnings per share for 2023 was CNY 2.29, with a return on equity of 10.51% [2] Product Sales Performance - The sales revenue of the Yangyuanqing anti-hair loss products exceeded CNY 300 million in 2023, marking a 36% year-on-year growth [3] - During the "Double 11" shopping festival, Yangyuanqing ranked first in the Tmall national anti-hair loss category and achieved over CNY 100 million in sales on Douyin [3] Oral Care Market - In 2023, Yunnan Baiyao toothpaste held a 24.60% market share in the domestic market, maintaining the leading position [4] - The flagship store on Tmall achieved over CNY 100 million in sales, becoming the first toothpaste single product to reach this milestone [4] - The company conducted over 14,700 offline promotional activities, covering 1,465 cities [4] Dividend Policy - In 2023, Yunnan Baiyao's dividend plan was CNY 20.77 per 10 shares, totaling CNY 3.706 billion, which accounted for 90.53% of the net profit attributable to shareholders [5] - The company has consistently paid dividends for 31 years since its listing, with cumulative cash dividends exceeding CNY 24.4 billion [5]